| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jiangtao Hong CEO | XSHE Exchange | CNE100000QM6 ISIN |
| China Country | 659 Employees | 13 Aug 2021 Last Dividend | 23 May 2014 Last Split | - IPO Date |
Honz Pharmaceutical Co., Ltd. is a prominent company based in Guangzhou, China, specializing in the research and development, manufacturing, and distribution of pediatric medicines. Since its inception in 1993, the company has dedicated itself to offering effective pharmaceutical solutions not only for children but also for adults across China. Operating under the name HaiNan Honz Pharmaceutical Co., Ltd. until November 2016, it then rebranded to its current name to presumably reflect its broadened vision and capabilities. Honz Pharmaceutical leverages a comprehensive network of agents and sales terminals to market its products, ensuring wide availability and access to its medicines.
The company prides itself on a diverse product portfolio that addresses a wide range of healthcare needs: